Decreased anxiety- and depression-like behaviors and hyperactivity in a type 3 deiodinase-deficient mouse showing brain thyrotoxicosis and peripheral hypothyroidism

Psychoneuroendocrinology

Volumn 74, Issue , 2016, Pages 46-56

  Stohn, J Patrizia ^a   Martinez, M Elena ^a   Hernandez, Arturo ^a  

^a Maine Medical Center Research Institute   (United States)

Author keywords

Anxiety; Depression; Dio3; Hyperactivity; Hyperthyroidism; Hypothyroidism

Indexed keywords

LIOTHYRONINE; THYROID HORMONE; THYROXINE DEIODINASE; IODIDE PEROXIDASE; IODOTHYRONINE DEIODINASE TYPE III;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY DISORDER; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DEPRESSION; ELEVATED PLUS MAZE TEST; ENZYME INACTIVATION; FEMALE; FORCED SWIM TEST; HOMEOSTASIS; HORMONE DEFICIENCY; HYPERACTIVITY; HYPOTHYROIDISM; MALE; NEUROPSYCHOLOGICAL TEST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; TAIL SUSPENSION TEST; THYROTOXICOSIS; 129 MOUSE; ANIMAL; ANXIETY; BLOOD; BRAIN; C57BL MOUSE; DEFICIENCY; DISEASE MODEL; METABOLISM; MOUSE; PATHOPHYSIOLOGY; RESTLESSNESS;

ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; BRAIN; DEPRESSION; DISEASE MODELS, ANIMAL; FEMALE; HYPOTHYROIDISM; IODIDE PEROXIDASE; MALE; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; PSYCHOMOTOR AGITATION; THYROTOXICOSIS;

EID: 84983504479     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2016.08.021     Document Type: Article

References (81)

1. Albacar, G., Sans, T., Martin-Santos, R., Garcia-Esteve, L., Guillamat, R., Sanjuan, J., Canellas, F., Carot, J.M., Gratacos, M., Bosch, J., Gaviria, A., Labad, A., Zotes, A.G., Vilella, E., Thyroid function 48 h after delivery as a marker for subsequent postpartum depression. Psychoneuroendocrinology 35 (2010), 738–742.
2. Andersen, S.L., Laurberg, P., Wu, C.S., Olsen, J., Attention deficit hyperactivity disorder and autism spectrum disorder in children born to mothers with thyroid dysfunction: a Danish nationwide cohort study. BJOG 121 (2014), 1365–1374.
3. Balemans, M.C., Huibers, M.M., Eikelenboom, N.W., Kuipers, A.J., van Summeren, R.C., Pijpers, M.M., Tachibana, M., Shinkai, Y., van Bokhoven, H., Van der Zee, C.E., Reduced exploration, increased anxiety, and altered social behavior: autistic-like features of euchromatin histone methyltransferase 1 heterozygous knockout mice. Behav. Brain Res. 208 (2010), 47–55.
4. Bauer, M., Baur, H., Berghofer, A., Strohle, A., Hellweg, R., Muller-Oerlinghausen, B., Baumgartner, A., Effects of supraphysiological thyroxine administration in healthy controls and patients with depressive disorders. J. Affect. Disord. 68 (2002), 285–294.
5. Bauer, M., London, E.D., Rasgon, N., Berman, S.M., Frye, M.A., Altshuler, L.L., Mandelkern, M.A., Bramen, J., Voytek, B., Woods, R., Mazziotta, J.C., Whybrow, P.C., Supraphysiological doses of levothyroxine alter regional cerebral metabolism and improve mood in bipolar depression. Mol. Psychiatry 10 (2005), 456–469.
6. Baumgartner, A., Campos-Barros, A., Gaio, U., Hessenius, C., Flechner, A., Meinhold, H., Carbamazepine affects triiodothyronine production and metabolization in rat hippocampus. Life Sci. 54 (1994), 401–407.
7. Benvenga, S., Lakshmanan, M., Trimarchi, F., Carnitine is a naturally occurring inhibitor of thyroid hormone nuclear uptake. Thyroid 10 (2000), 1043–1050.
8. Benvenga, S., Itri, E., Hauser, P., De Tolla, L., Yu, S.F., Testa, G., Pappalardo, M.A., Trimarchi, F., Amato, A., Gender differences in locomotor and stereotypic behavior associated with l-carnitine treatment in mice. Gend Med. 8 (2011), 1–13.
9. Berent, D., Zboralski, K., Orzechowska, A., Galecki, P., Thyroid hormones association with depression severity and clinical outcome in patients with major depressive disorder. Mol. Biol. Rep. 41 (2014), 2419–2425.
10. Bianco, A.C., Minireview: cracking the metabolic code for thyroid hormone signaling. Endocrinology 152 (2011), 3306–3311.
11. Buras, A., Battle, L., Landers, E., Nguyen, T., Vasudevan, N., Thyroid hormones regulate anxiety in the male mouse. Horm. Behav. 65 (2014), 88–96.
12. Campos-Barros, A., Meinhold, H., Stula, M., Muller, F., Kohler, R., Eravci, M., Putzien, O., Baumgartner, A., The influence of desipramine on thyroid hormone metabolism in rat brain. J. Pharm. Exp. Ther. 268 (1994), 1143–1152.
13. Chatonnet, F., Flamant, F., Morte, B., A temporary compendium of thyroid hormone target genes in brain. Biochim. Biophys. Acta 1849 (2015), 122–129.
14. Chueire, V.B., Romaldini, J.H., Ward, L.S., Subclinical hypothyroidism increases the risk for depression in the elderly. Arch. Gerontol. Geriatr. 44 (2007), 21–28.
15. Cleare, A.J., McGregor, A., O'Keane, V., Neuroendocrine evidence for an association between hypothyroidism, reduced central 5-HT activity and depression. Clin. Endocrinol. (Oxf.) 43 (1995), 713–719.
16. Constant, E.L., Adam, S., Seron, X., Bruyer, R., Seghers, A., Daumerie, C., Anxiety and depression attention, and executive functions in hypothyroidism. J. Int. Neuropsychol. Soc.: JINS 11 (2005), 535–544.
17. Craddock, N., O'Donovan, M.C., Owen, M.J., The genetics of schizophrenia and bipolar disorder: dissecting psychosis. J. Med. Genet. 42 (2005), 193–204.
18. Custro, N., Scafidi, V., Lo Baido, R., Nastri, L., Abbate, G., Cuffaro, M.P., Gallo, S., Vienna, G., Notarbartolo, A., Subclinical hypothyroidism resulting from autoimmune thyroiditis in female patients with endogenous depression. J. Endocrinol. Invest. 17 (1994), 641–646.
19. Darbra, S., Garau, A., Balada, F., Sala, J., Marti-Carbonell, M.A., Perinatal hypothyroidism effects on neuromotor competence, novelty-directed exploratory and anxiety-related behaviour and learning in rats. Behav. Brain Res. 143 (2003), 209–215.
20. Dayan, C.M., Panicker, V., Hypothyroidism and depression. Eur. Thyroid J. 2 (2013), 168–179.
21. DeLorey, T.M., Sahbaie, P., Hashemi, E., Li, W.W., Salehi, A., Clark, D.J., Somatosensory and sensorimotor consequences associated with the heterozygous disruption of the autism candidate gene, Gabrb3. Behav. Brain Res. 216 (2011), 36–45.
22. Deacon, R.M.J., Digging and marble burying in mice: simple methods for in vivo identification of biological impacts. Nat. Protoc. 1 (2006), 122–124.
23. Demet, M.M., Ozmen, B., Deveci, A., Boyvada, S., Adiguzel, H., Aydemir, O., Depression and anxiety in hyperthyroidism. Arch. Med. Res. 33 (2002), 552–556.
24. DonCarlos, L.L., Developmental profile and regulation of estrogen receptor (ER) mRNA expression in the preoptic area of prenatal rats. Brain Res. Dev. Brain Res. 94 (1996), 224–233.
25. Duval, F., Mokrani, M.C., Crocq, M.A., Bailey, P., Macher, J.P., Influence of thyroid hormones on morning and evening TSH response to TRH in major depression. Biol. Psychiatry 35 (1994), 926–934.
26. Escamez, M.J., Guadano-Ferraz, A., Cuadrado, A., Bernal, J., Type 3 iodothyronine deiodinase is selectively expressed in areas related to sexual differentiation in the newborn rat brain. Endocrinology 140 (1999), 5443–5446.
27. Fava, M., Labbate, L.A., Abraham, M.E., Rosenbaum, J.F., Hypothyroidism and hyperthyroidism in major depression revisited. J. Clin. Psychiatry 56 (1995), 186–192.
28. Feyder, M., Karlsson, R.M., Mathur, P., Lyman, M., Bock, R., Momenan, R., Munasinghe, J., Scattoni, M.L., Ihne, J., Camp, M., Graybeal, C., Strathdee, D., Begg, A., Alvarez, V.A., Kirsch, P., Rietschel, M., Cichon, S., Walter, H., Meyer-Lindenberg, A., Grant, S.G., Holmes, A., Association of mouse Dlg4 (PSD-95) gene deletion and human DLG4 gene variation with phenotypes relevant to autism spectrum disorders and Williams' syndrome. Am. J. Psychiatry 167:December (12) (2010), 1508–1517.
29. Frye, M.A., Dunn, R.T., Gary, K.A., Kimbrell, T.A., Callahan, A.M., Luckenbaugh, D.A., Cora-Locatelli, G., Vanderham, E., Winokur, A., Post, R.M., Lack of correlation between cerebrospinal fluid thyrotropin-releasing hormone (TRH) and TRH-stimulated thyroid-stimulating hormone in patients with depression. Biol. Psychiatry 45 (1999), 1049–1052.
30. Galton, V.A., de Waard, E., Parlow, A.F., St Germain, D.L., Hernandez, A., Life without the iodothyronine deiodinases. Endocrinology 155 (2014), 4081–4087.
31. Ge, J.F., Peng, Y.Y., Qi, C.C., Chen, F.H., Zhou, J.N., Depression-like behavior in subclinical hypothyroidism rat induced by hemi-thyroid electrocauterization. Endocrine 45 (2014), 430–438.
32. Gur, E., Lifschytz, T., Van de Kar, L.D., Lerer, B., Newman, M.E., Effects of triiodothyronine on 5-HT1a and 5-HT1b autoreceptor activity, and postsynaptic 5-HT1a receptor activity, in rat hypothalamus: lack of interaction with imipramine. Psychoneuroendocrinology 29 (2004), 1172–1183.
33. Haggerty, J.J. Jr., Prange, A.J. Jr., Borderline hypothyroidism and depression. Annu. Rev. Med. 46 (1995), 37–46.
34. Hernandez, A., Fiering, S., Martinez, E., Galton, V.A., St Germain, D., The gene locus encoding iodothyronine deiodinase type 3 (Dio3) is imprinted in the fetus and expresses antisense transcripts. Endocrinology 143 (2002), 4483–4486.
35. Hernandez, A., Martinez, M.E., Fiering, S., Galton, V.A., St Germain, D., Type 3 deiodinase is critical for the maturation and function of the thyroid axis. J. Clin. Invest. 116 (2006), 476–484.
36. Hernandez, A., Quignodon, L., Martinez, M.E., Flamant, F., St Germain, D.L., Type 3 deiodinase deficiency causes spatial an temporal alterations in brain T3 signaling that are dissociated from serum thyroid hormone levels. Endocrinology 151 (2010), 5550–5558.
37. Hernandez, A., Structure and function of the type 3 deiodinase gene. Thyroid 15 (2005), 865–874.
38. Joffe, R.T., Marriott, M., Thyroid hormone levels and recurrence of major depression. Am. J. Psychiatry 157 (2000), 1689–1691.
39. Joffe, R.T., Sokolov, S.T., Thyroid hormone treatment of primary unipolar depression: a review. Int. J. Neuropsychopharmacol. 3 (2000), 143–147.
40. Joffe, R.T., Sokolov, S.T., Singer, W., Thyroid hormone treatment of depression. Thyroid 5 (1995), 235–239.
41. Kim, E.Y., Kim, S.H., Rhee, S.J., Huh, I., Ha, K., Kim, J., Chang, J.S., Yoon, D.H., Park, T., Ahn, Y.M., Relationship between thyroid-stimulating hormone levels and risk of depression among the general population with normal free T4 levels. Psychoneuroendocrinology 58 (2015), 114–119.
42. Kirkegaard, C., Faber, J., Influence of free thyroid hormone levels on the TSH response to TRH in endogenous depression. Psychoneuroendocrinology 11 (1986), 491–497.
43. Lasser, R.A., Baldessarini, R.J., Thyroid hormones in depressive disorders: a reappraisal of clinical utility. Harv. Rev. Psychiatry 4 (1997), 291–305.
44. Lotan, A., Fenckova, M., Bralten, J., Alttoa, A., Dixson, L., Williams, R.W., van der Voet, M., Neuroinformatic analyses of common and distinct genetic components associated with major neuropsychiatric disorders. Front. Neurosci., 8, 2014, 331.
45. Lucas, A., Pizarro, E., Granada, M.L., Salinas, I., Sanmarti, A., Postpartum thyroid dysfunction and postpartum depression: are they two linked disorders?. Clin. Endocrinol. (Oxf.) 55 (2001), 809–814.
46. Martinez, M.E., Charalambous, M., Saferali, A., Fiering, S., Naoumova, A., St Germain, D.L., Ferguson-Smith, A., Hernandez, A., Genomic imprinting variations in the mouse type 3 deiodinase gene between tissues and brain regions. Mol. Endocrinol. 28 (2014), 1875–1886.
47. Martinez, M.E., Cox, D.F., Youth, B.P., Hernandez, A., Genomic imprinting of DIO3, a candidate gene for the syndrome associated with human uniparental disomy of chromosome 14. Eur. J. Hum. Genet., 2016, 10.1038/ejhg.2016.66 (advance online publication).
48. Mason, G.A., Bondy, S.C., Nemeroff, C.B., Walker, C.H., Prange, A.J. Jr., The effects of thyroid state on beta-adrenergic and serotonergic receptors in rat brain. Psychoneuroendocrinology 12 (1987), 261–270.
49. Matzel, L.D., Babiarz, J., Townsend, D.A., Grossman, H.C., Grumet, M., Neuronal cell adhesion molecule deletion induces a cognitive and behavioral phenotype reflective of impulsivity. Genes Behav. 7 (2008), 470–4480.
50. Medici, M., Direk, N., Visser, W.E., Korevaar, T.I., Hofman, A., Visser, T.J., Tiemeier, H., Peeters, R.P., Thyroid function within the normal range and the risk of depression: a population-based cohort study. J. Clin. Endocrinol. Metab. 99 (2014), 1213–1219.
51. Modesto, T., Tiemeier, H., Peeters, R.P., Jaddoe, V.W., Hofman, A., Verhulst, F.C., Ghassabian, A., Maternal mild thyroid hormone insufficiency in early pregnancy and attention-Deficit/Hyperactivity disorder symptoms in children. JAMA Pediatr. 169 (2015), 838–845.
52. Moy, S.S., Riddick, N.V., Nikolova, V.D., Teng, B.L., Agster, K.L., Nonneman, R.J., Young, N.B., Baker, L.K., Nadler, J.J., Bodfish, J.W., Repetitive behavior profile and supersensitivity to amphetamine in the C58/: J mouse model of autism. Behav. Brain Res. 259 (2014), 200–214.
53. Negishi, T., Kawasaki, K., Sekiguchi, S., Ishii, Y., Kyuwa, S., Kuroda, Y., Yoshikawa, Y., Attention-deficit and hyperactive neurobehavioural characteristics induced by perinatal hypothyroidism in rats. Behav. Brain Res. 159 (2005), 323–331.
54. Ng, L., Goodyear, R.J., Woods, C.A., Schneider, M.J., Diamond, E., Richardson, G.P., Kelley, M.W., St Germain, D., Galton, V.A., Forrest, D., Hearing loss and retarded cochlear development in mice lacking type 2 iodothyronine deiodinase. Proc. Natl. Acad. Sci. U. S. A. 101 (2004), 3474–3479.
55. Ng, L., Hernandez, A., He, W., Ren, T., Srinivas, M., Ma, M., Galton, V.A., St Germain, D.L., Forrest, D., A protective role for type 3 deiodinase, a thyroid hormone-inactivating enzyme, in cochlear development and auditory function. Endocrinology 150 (2009), 1952–1960.
56. Njung'e, K., Handley, S.L., Effects of 5-HT uptake inhibitors, agonists and antagonists on the burying of harmless objects by mice; a putative test for anxiolytic agents. Br. J. Pharmacol. 104 (1991), 105–112.
57. Njung'e, K., Handley, S.L., Evaluation of marble-burying behavior as a model of anxiety. Pharmacology. Biochem. Behav. 38 (1991), 63–67.
58. O'Leary, T.P., Gunn, R.K., Brown, R.E., What are we measuring when we test strain differences in anxiety in mice?. Behav. Genet. 43 (2013), 34–50.
59. Park, Y.J., Lee, E.J., Lee, Y.J., Choi, S.H., Park, J.H., Lee, S.B., Lim, S., Lee, W.W., Jang, H.C., Cho, B.Y., Woo, J.I., Kim, K.W., Subclinical hypothyroidism (SCH) is not associated with metabolic derangement, cognitive impairment, depression or poor quality of life (QoL) in elderly subjects. Arch. Gerontol. Geriatr. 50 (2010), e68–73.
60. Pedersen, C.A., Johnson, J.L., Silva, S., Bunevicius, R., Meltzer-Brody, S., Hamer, R.M., Leserman, J., Antenatal thyroid correlates of postpartum depression. Psychoneuroendocrinology 32 (2007), 235–245.
61. Plaza, A., Garcia-Esteve, L., Ascaso, C., Navarro, P., Gelabert, E., Halperin, I., Valdes, M., Martin-Santos, R., Childhood sexual abuse and hypothalamus-pituitary-thyroid axis in postpartum major depression. J. Affect. Disord. 122 (2010), 159–163.
62. Prange, A.J. Jr., Novel uses of thyroid hormones in patients with affective disorders. Thyroid 6 (1996), 537–543.
63. Roskoden, T., Zilles, K., Schleicher, A., Schwegler, H., Transient postnatal thyroxine treatment leads to variation in transmitter binding site densities in the hippocampus of rats. Neurosci. Lett. 333 (2002), 21–24.
64. Shelton, R.C., Winn, S., Ekhatore, N., Loosen, P.T., The effects of antidepressants on the thyroid axis in depression. Biol. Psychiatry 33 (1993), 120–126.
65. Shukla, P.K., Sittig, L.J., Andrus, B.M., Schaffer, D.J., Batra, K.K., Redei, E.E., Prenatal thyroxine treatment disparately affects peripheral and amygdala thyroid hormone levels. Psychoneuroendocrinology 35 (2010), 791–797.
66. Silverman, J.L., Pride, M.C., Hayes, J.E., Puhger, K.R., Butler-Struben, H.M., Baker, S., Crawley, J.N., GABAB receptor agonist R-Baclofen reverses social deficits and reduces repetitive behavior in two mouse models of autism. Neuropsychopharmacology 40 (2015), 2228–2239.
67. Simon, N.M., Blacker, D., Korbly, N.B., Sharma, S.G., Worthington, J.J., Otto, M.W., Pollack, M.H., Hypothyroidism and hyperthyroidism in anxiety disorders revisited: new data and literature review. J. Affect. Disord. 69 (2002), 209–217.
68. Sinai, C., Hirvikoski, T., Dencker Vansvik, E., Nordstrom, A.L., Linder, J., Nordstrom, P., Jokinen, J., Thyroid hormones and personality traits in attempted suicide. Psychoneuroendocrinology 34 (2009), 1526–1532.
69. Sittig, L.J., Herzing, L.B., Shukla, P.K., Redei, E.E., Parent-of-origin allelic contributions to deiodinase-3 expression elicit localized hyperthyroid milieu in the hippocampus. Mol. Psychiatry 16 (2011), 786–787.
70. Sittig, L.J., Shukla, P.K., Herzing, L.B., Redei, E.E., Strain-specific vulnerability to alcohol exposure in utero via hippocampal parent-of-origin expression of deiodinase-III. FASEB J. 25 (2011), 2313–2324.
71. Targum, S.D., Greenberg, R.D., Harmon, R.L., Kessler, K., Salerian, A.J., Fram, D.H., The TRH test and thyroid hormone in refractory depression. Am. J. Psychiatry, 141, 1984, 463.
72. Tsai, C., Lin, S.P., Ito, M., Takagi, N., Takada, S., Ferguson-Smith, A.C., Genomic Imprinting contributes to thyroid hormone metabolism in the mouse embryo. Curr. Biol. 12 (2002), 1221–1226.
73. Vasudevan, N., Zhu, Y.S., Daniel, S., Koibuchi, N., Chin, W.W., Pfaff, D., Crosstalk between oestrogen receptors and thyroid hormone receptor isoforms results in differential regulation of the preproenkephalin gene. J. Neuroendocrinol. 13 (2001), 779–790.
74. Vasudevan, N., Kia, H.K., Inoue, S., Muramatsu, M., Pfaff, D., Isoform specificity for oestrogen receptor and thyroid hormone receptor genes and their interactions on the NR2D gene promoter. J. Neuroendocrinol. 14 (2002), 836–842.
75. Venero, C., Guadano-Ferraz, A., Herrero, A.I., Nordstrom, K., Manzano, J., de Escobar, G.M., Bernal, J., Vennstrom, B., Anxiety, memory impairment, and locomotor dysfunction caused by a mutant thyroid hormone receptor alpha1 can be ameliorated by T3 treatment. Genes. Dev. 19 (2005), 2152–2163.
76. Wallis, K., Sjogren, M., van Hogerlinden, M., Silberberg, G., Fisahn, A., Nordstrom, K., Larsson, L., Westerblad, H., Morreale de Escobar, G., Shupliakov, O., Vennstrom, B., Locomotor deficiencies and aberrant development of subtype-specific GABAergic interneurons caused by an unliganded thyroid hormone receptor alpha1. J. Neurosci. 28 (2008), 1904–1915.
77. Wasco, E.C., Martinez, E., Grant, K.S., St Germain, E.A., St Germain, D.L., Galton, V.A., Determinants of iodothyronine deiodinase activities in rodent uterus [see comment]. Endocrinology 144 (2003), 4253–4261.
78. Yu, D., Zhou, H., Yang, Y., Jiang, Y., Wang, T., Lv, L., Zhou, Q., Yang, Y., Dong, X., He, J., Huang, X., Chen, J., Wu, K., Xu, L., Mao, R., The bidirectional effects of hypothyroidism and hyperthyroidism on anxiety- and depression-like behaviors in rats. Horm. Behav. 69 (2015), 106–115.
79. Zeng, H., Schimpf, B.A., Rohde, A.D., Pavlova, M.N., Gragerov, A., Bergmann, J.E., Thyrotropin-releasing hormone receptor 1-deficient mice display increased depression and anxiety-like behavior. Mol. Endocrinol. 21 (2007), 2795–2804.
80. van Enkhuizen, J., Geyer, M.A., Halberstadt, A.L., Zhuang, X., Young, J.W., Dopamine depletion attenuates some behavioral abnormalities in a hyperdopaminergic mouse model of bipolar disorder. J. Affect. Disord. 155 (2014), 247–254.
81. van der Deure, W.M., Appelhof, B.C., Peeters, R.P., Wiersinga, W.M., Wekking, E.M., Huyser, J., Schene, A.H., Tijssen, J.G., Hoogendijk, W.J., Visser, T.J., Fliers, E., Polymorphisms in the brain-specific thyroid hormone transporter OATP1C1 are associated with fatigue and depression in hypothyroid patients. Clin. Endocrinol. (Oxf.) 69 (2008), 804–811.